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Helminths are extraordinarily successful parasites due to their ability tomodulate the host immune response.
They have evolved a spectrum of immunomodulatory molecules that are now beginning to be defined,
heralding a molecular revolution in parasite immunology. These discoveries have the potential both to trans-
form our understanding of parasite adaptation to the host and to develop possible therapies for immune-
mediated disease. In this review we will summarize the current state of the art in parasite immunomodulation
and discuss perspectives on future areas for research and discovery.Introduction
Helminths are extremely successful parasites, affecting around a
quarter of the world’s population (Bethony et al., 2006). They
establish chronic infections and if untreated can persist for the
lifetime of the host. While the immune system is capable of para-
site expulsion (often incurring collateral damage), in natural
infections there is frequently a muted immune response in which
the host accommodates, and tolerates, the invader. Such
re-setting of host immunity results from both host reparative re-
sponses to physical damage from tissue-migrating parasites
and/or through active immunomodulation by their molecular
products. The ability of parasites to defy host immunity reflects
their masterful manipulation of the immune system, which as
detailed below, is achieved through the release of a spectrum
of finely tuned and highly evolved immuno-modulatory factors
(Table 1).
Recent advances in helminth genomics and proteomics have
uncovered a wealth of such immunomodulatory products. These
act on every phase of the immune response, which for the pur-
poses of this reviewwe have divided into: (1) initiation, (2) antigen
recognition and processing, (3) adaptive responses, (4) effector
cell responses, and (5) coagulation, healing, and remodeling.
Parasite immunomodulators active at each phase can be found
that either share ancestral homology with host genes or have
developed de novo, sharing no identifiable homology to the
host (Figure 1). Here, we summarize the molecular actors known
to interact at each step and their evolutionary and structural
provenance, and we discuss future prospects for this
exciting field.
Parasites Neutralize Initiating Alarmin Signals
Immune responses are initiated by danger signals, through
detection of damage-associated molecular patterns (DAMPs)
or introduction of pathogen-associated molecular patterns
(PAMPs). Parasite migration induces DAMPs and introduces
PAMPs from either the parasite itself or bacteria entering tissues
through compromised barriers. The imperative to mute barriersurface reactions has driven the evolution of potent mechanisms
to suppress innate immune responses (Figure 2).
Activation of epithelial cells results in the release of ‘‘alarmin’’
cytokines such as thymic stromal lymphopoietin (TSLP), inter-
leukin-25 (IL-25), and IL-33. IL-33 is tightly spatiotemporally
controlled: it is released on epithelial necrosis and then rapidly
oxidized and inactivated (Cohen et al., 2015). The murine intesti-
nal nematode Heligmosomoides polygyrus suppresses IL-33
release through HpARI (H. polygyrus alarmin release inhibitor)
(McSorley et al., 2014; Osbourn et al., 2017) within its excre-
tory-secretory (ES) products. HpARI has a selective mode of
action, binding DNA via its first domain, while the second and
third domains bind to reduced (active) but not oxidized (inactive)
IL-33. Binding obstructs interaction of the complex with the IL-33
receptor, ST2, while interaction with DNA tethers IL-33 within the
nucleus of necrotic cells, preventing IL-33 release. HpARI
administration ablates type 2 cell-mediated inflammation and
improves lung function in an Alternaria allergen-dependent
asthma model, while in Nippostrongylus brasiliensis infection,
HpARI administration suppresses type 2 responses and
increased worm burden. Crucially, these effects translate to
the human setting, as HpARI prevents IL-33 release from human
lung explants and blocks human IL-33 release in a transgenic
mouse model (Osbourn et al., 2017).
H. polygyrus suppresses the IL-33 pathway at multiple levels
additionally to HpARI, with an undefined H. polygyrus product
further downregulating IL-33 production through induction of
IL-1b (Zaiss et al., 2013) and through the release of small RNA-
containing extracellular vesicles that suppress transcription of
the IL-33 receptor (Buck et al., 2014; Coakley et al., 2017).
IL-33 release can be provoked by signals of cell stress or
death, in particular extracellular ATP, which induces epithelial
and mast cell IL-33 production (Cekic and Linden, 2016). Many
parasite secretions contain apyrases (Da’dara et al., 2014; Gou-
naris et al., 2004), which degrade ATP to non-inflammatory AMP,
reducing inflammatory DAMP signals, and hence these could
inhibit this important arm of the damage detection response.Immunity 49, November 20, 2018 ª 2018 Elsevier Inc. 801
Table 1. Different Classes of Helminth-Derived Immunomodulatory Molecules
Abbreviation Helminth Species Action References
Cytokine & Innate Defense Homologs and Growth Factors
Alarmin release inhibitor HpARI Heligmosomoides polygyrus Blocks human and mouse IL-33 Osbourn et al., 2017
Asparaginyl-tRNA
synthetase
AsnRS Brugia malayi Structural homology to IL-8, binds IL-8 receptors
CXCR1 and CXCR2; chemotactic for neutrophils
and eosinophils; induced regulatory responses and
IL-10 in a T cell transfer model of colitis
Kron et al., 2013
Chemokine binding
protein
SmCKBP Schistosoma mansoni Neutralizes chemokine activity (CXCL8, CCL3, CX3CL1,
CCL2, CCL5); inhibits neutrophil migration but not
eosinophil migration
Smith et al., 2005
Granulin-like growth
factor-1
OvGRN-1 Opisthorchis viverrini Induces angiogenesis and wound healing (mice);
proliferation in human cholangiocytes and pathways
associated with wound healing and cancer
Smout et al., 2009, 2015
Helminth defense
molecule-1
FhHDM-1 Fasciola hepatica Molecular mimicry of antimicrobial peptide CAP18/
LL-37, binds to LPS and reduces its activity; prevents
acidification of the endolysosomal compartments and
antigen processing; prevents NLRP3 inflammasome
activation
Robinson et al., 2011, 2012
IL-4 inducing principle
from S. mansoni eggs
IPSE S. mansoni; S. haematobium Induces IL-4 secretion in basophils via binding to IgE;
induces IL-10 in B cells and enhances their capacity
to induce Treg cells; translocates to nucleus and
reduces bladder hemorrhage in vivo
Haeberlein et al., 2017; Kaur
et al., 2011; Mbanefo et al., 2018
Macrophage Migration
Inhibitory Factor homolog-1
MIF-1 B. malayi, Trichinella spiralis,
Anisakis simplex
Induces IL-8 release from monocytes; synergizes with
IL-4 to induce alternatively activated macrophages;
inhibits experimental arthritis, colitis & allergic airway
inflammation via induction of IL-10 & Treg cells
Cho et al., 2015; Park et al., 2009;
Tan et al., 2001; Zang et al., 2002
Metalloproteinases – Necator americanus Causes proteolysis of eotaxin, but not of IL-8 or eotaxin-2 Culley et al., 2000
Neutrophil inhibitory factor AcNIF Ancylostoma caninum Binds b2 integrin CD11b/CD18, inhibit LPS-induced
neutrophil migration and release of reactive oxygen
species (ROS)
Anbu and Joshi, 2008; Moyle et al.,
1994; Zhou et al., 199855 kDa glycoprotein Hcgp55 Haemonchus contortus
T cell immunomodulatory
protein
EmTIP Echinococcus multilocularis Induces release of IFN-g from CD4+ T cells in vitro Nono et al., 2014
TGF-b homolog-2 TGH-2 B. malayi Ligates mammalian TGF-b receptor and suppresses T cell
responses
Gomez-Escobar et al., 2000
TGF-b mimic TGM H. polygyrus Ligation of TGF-b receptor on T cells leading to induction
of Treg cells
Grainger et al., 2010; Johnston
et al., 2017
TGF-like molecule FhTLM F. hepatica Ligates mammalian TGF-b receptor (albeit with a lower
affinity) and induces IL-10 and Arginase in macrophages
Sulaiman et al., 2016
(Continued on next page)
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Table 1. Continued
Abbreviation Helminth Species Action References
TLR Signaling
ES-62 ES-62 Acanthocheilonema viteae Modulates dendritic cell responses by inducing the
selective autophagolysosomal degradation of
TLR-transducers (e.g., TLR4) and interaction with
MyD88; synthetic variants block inflammation in
various disease models, i.e., allergy, rheumatoid arthritis, and colitis
Ball et al., 2018; Goodridge et al.,
2007; Pineda et al., 2014;
Rzepecka et al., 2014
Fatty acid binding
protein
Fh12/15 F. hepatica Suppresses LPS-induced activation via binding and
blocking of CD14; induction of alternatively activated
macrophages
Martin et al., 2015;
Ramos-Benı´tez et al., 2017
Lysophosphatidylserine Lyso-PS S. mansoni Ligation of TLR2 on dendritic cells; licenses DCs to
develop IL-10-producing Treg cells
van der Kleij et al., 2002
Mucin-like polypeptide Fhmuc F. hepatica Promotes TLR4 activation of DCs and Th1 cell induction Noya et al., 2016, 2017
Intracellular Signaling and Gene Expression
Abundant Larval
Transcript
ALT B. malayi Upregulates SOCS1, the inhibitor of IFN-g signaling Gomez-Escobar et al., 2005
Acetylcholinesterase AChE N. brasiliensis Degrades acetylcholine, reduces neural signaling;
induces proinflammatory cytokines with diminished
type 2 cytokines in transgenic AChE-expressing
trypanosome infection
Vaux et al., 2016
Ancylostoma secreted
protein-2
NaASP-2 N. americanus Binding to CD79A on B cells, downregulation of lyn,
PI3K, and BCR signaling
Tribolet et al., 2015
ATP diphosphohydrolase SmATPDase1 S. mansoni Degradation of the exogenous pro-inflammatory and
pro-thrombotic nucleotides ATP and ADP: inhibition
of blood coagulation
Da’dara et al., 2014
Calpain-1 & 2 SmCalp-1,
SmCalp-2
S. mansoni SmCalp1 and -2 cleave the blood clotting protein
fibronectin and high-molecular-weight kininogen (HK)
Wang et al., 2017
Cathepsin L peptidases FhCL-1,-2,-3 F. hepatica Degrades fibrinogen and fibrin Mebius et al., 2018
Ectonucleotide
pyrophosphatase/
phosphodiesterase
SmNPP-5 S. mansoni Ectonucleotide pyrophosphatase/phosphodiesterase
homolog, which inhibits platelet aggregation by
degradation of ADP
Elzoheiry et al., 2018
a-enolase OvENO Onchocerca volvulus Binds to plasminogen and supports plasmin-mediated
proteolysis including degradation of host’s extracellular
matrix
Jolodar et al., 2003
Inhibitor of potassium
channel
AcK1 A. caninum Inhibitor of the voltage-gated channel Kv1.3 in
lymphocytes, similar to the polypeptide inhibitor of
the sea anemone, Skh; suppressed delayed type
hypersensitivity and the proliferation of memory T cells
Chhabra et al., 2014
BmK1 B. malayi
(Continued on next page)
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Table 1. Continued
Abbreviation Helminth Species Action References
Omega-1 u-1 S. mansoni T2 ribonuclease binds to MR and DC-SIGN, after
uptake degrades ribosomal and mRNA; primes DCs
for enhances Th2 development; enhances IL-1b
secretion in macrophages; improves insulin sensitivity
Everts et al., 2009, 2012;
Ferguson et al., 2015; Hams
et al., 2016; Ke et al., 2017;
Steinfelder et al., 2009;
Wilbers et al., 2017
CP1412 S. japonicum
Serine protease-2 SmSP-2 S. mansoni Manipulation host vasodilatation and fibrinolysis:
activates tissue plasminogen activator and plasminogen
Leontovyc et al., 2018
16 kDa polypeptide Sj16 S. japonicum Translocates to the nucleus, induces IL-10 in BM-derived DCs Sun et al., 2016
Enzymes and Inhibitors
Anti-inflammatory
protein-1
AIP-1 N. americanus Family member of tissue inhibitor of metalloprotease
(TIMP)-like proteins; suppression in TNBS colitis model:
promotes expression of colon IL-10, TGF-b, and TSLP
and the accumulation of Treg cells in the colon
Ferreira et al., 2017
Anti-inflammatory
protein-2
AIP-2 N. americanus Family member of TIMP-like proteins; suppression in
model of allergic airway inflammation via Treg cell induction
and suppression of T cell proliferation in cells from house
dust mite (HDM)-allergic patients
Navarro et al., 2016
Cystatins AvCystatin A. viteae Induction of regulatory IL-10-producing macrophages and
hyporesponsive T cells; compromised APC function;
reduced airway allergy and intestinal colitic inflammation
in mouse models
Dani1owicz-Luebert et al.,
2013; Ziegler et al., 2015
Onchocystatin O. volvulus Scho¨nemeyer et al., 2001
LsCystatin Litomosoides sigmodontis Pfaff et al., 2002
HpCPI H. polygyrus Sun et al., 2013
BmCPI-2 B. malayi Manoury et al., 2001
Nippocystatin N. brasiliensis Dainichi et al., 2001
rSjCystatin S. japonicum Wang et al., 2016
rAi-CPI Aacaris lumbricoides Coronado et al., 2017
rCsStefin-1 Clonorchis sinensis Jang et al., 2011
Kunitz-type serine
protease inhibitor
SjKT-1 S. japonicum Inhibition of trypsin and chymotrypsin, neutrophil elastase,
FXa, and plasma kallikrein: both anti-coagulant and anti-
inflammatory properties. FhKTM reduces inflammatory
cytokine production in DC
Falco´n et al., 2014;
Ranasinghe et al., 2015FhKTM F. hepatica
Peroxiredoxin FhPrx F. hepatica Anti-oxidant enzyme: inactivation of ROS and induction of
AA-MF in mouse models
Donnelly et al., 2008
Thioredoxin peroxidase TPx F. hepatica Anti-oxidant enzyme, induction of AA-MF with increased
IL-10 and PGE2 responses
Donnelly et al., 2005
Tissue inhibitor of
metalloprotease
Ace-MTP-2 A. ceylanicum Reduces MHC-I and MHCII molecules on dendritic cells
and those DC induce CD4 and CD8 Treg cells
Ba˛ska et al., 2013
(Continued on next page)
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Table 1. Continued
Abbreviation Helminth Species Action References
Lipid or Lipid-Binding
Protein of Ascaris suum-1 PAS-1 Ascaris suum Similar to ABA-1, a nematode tandemly repeated polyprotein
with lipid binding properties; inhibitory in an experimental
airway allergy model, dependent on IL-10-producing Treg
cells and IFN-g-producing CD8gdTCR T cells
Arau´jo et al., 2008;
de Arau´jo et al., 2010
Prostaglandin-2 PGE2 Trichuris suis T. suis secretes large amounts of PGE2 in a
COX-independent pathway; secreted PGE2 is
effective in modulating DC responses
Kaisar et al., 2018; Laan
et al., 2017; Liu et al., 1992
S. mansoni Ligation to Dectin1 and Dectin 2 on DC by SEA
leads to autocrine production of PGE2 in DC,
which lead to increased Th2 polarization
Extracellular Vesicles
Extracellular vesicles EV H. polygyrus EVs contain microRNAs that target epithelial
cells and macrophages leading to loss of IL-33
receptor (IL-33R, also termed ST2) expression,
and downregulate other immune genes; inhibit
eosinophilia in Alternaria allergic airway
inflammation model
Buck et al., 2014;
Coakley et al., 2017
Extracellular vesicles EV S. japonicum Induce M1 macrophage differentiation in vitro Wang et al., 2015
Im
m
u
n
ity
4
9
,
N
o
v
e
m
b
e
r
2
0
,
2
0
1
8
8
0
5
Im
m
u
n
ity
R
e
v
ie
w
ILC2
1. Initiation
2. Antigen 
recognition and 
processing
DC
Mac
Th2
cell
B
cell
3. Adaptive 
responses Treg
cell
4. Effector Cell 
Responses
5. Healing and 
RemodelingDC
ddMac
Y Th1
cell
Th17 
cell
ES62/PC
PGE2
Fh-HDM-1
Fh12/Fh15
FhCLI-1
FhPRX
Ac-TMP-2
MIF
Cystatin
Lyso-PS
ω-1
AIP-1
AIP-2
Apyrase
AChE
HpARI
Bm-TGH-2         HpTGM         Na-ASP-2        IPSE
Proteases
Ov-GRN-1
BmAsnRS
SmCKBP
AcNIF 
Hcgp55
Parasite products homologous/
chemically similar to host factors
Parasite products with neither sequence nor 
functional homology to host factors
Figure 1. Helminth Modulators Act at All
Phases of the Immune Response
Modulatory proteins can be homologous to host
genes (shared evolutionary ancestry, green) or
show no homology (developed de novo, red). The
immune response is divided into five phases: (1)
initiation, innate recognition of damage and
danger; (2) innate cell activation and antigen pre-
sentation; (3) adaptive immune responses; (4)
effector immune responses; and (5) resolution and
healing.
Immunity
ReviewHelminths Target Dendritic Cell and Macrophage
Functions
A pivotal point in host immunity is recognition of and reaction to
pathogen molecules, typically by pathogen- or damage-associ-
ated molecules patterns (PAMPs and DAMPs) ligating pattern
recognition receptors (PRRs) on myeloid cells, such as toll-like
receptors (TLRs) and C-type lectin receptors (CLRs). These re-
actions are intensively targeted by helminth molecules (Figure 2),
which block TLR ligand-induced dendritic cell and macrophage
activation, interfering with receptors and their signaling, as well
as antigen presentation and downstream effector mechanisms.
The MyD88 adaptor protein is required for signaling via all
TLRs except TLR3, and also IL-1 family cytokine receptors
(including the IL-33 receptor). ES-62, a multifunctional glycopro-
tein secreted by the rodent filarial nematode Acanthocheilonema
viteae (Pineda et al., 2014), protects against pathology in mouse
models of rheumatoid arthritis (RA) (Doonan et al., 2018), asthma
(Rzepecka et al., 2014), and lung fibrosis (Suckling et al., 2018).
ES-62 induces sequestration of the MyD88 signaling protein,
leading to suppression of TLR and IL-33 signaling (Ball et al.,
2018; Pineda et al., 2014). The immunomodulatory principle of
ES-62 is phosphorylcholine (PC) side groups carried on N-linked
glycan moieties (Goodridge et al., 2007), and synthetic small
molecule variants of PC can reproduce many anti-inflammatory
effects of the parent molecule (Al-Riyami et al., 2013).
A different mechanism is deployed by the immunomodulatory
ES protein Fh12 (and its recombinant form, Fh15) from the liver
fluke Fasciola hepatica. The Fh12 and Fh15 proteins induce
alternative activation in human monocyte-derived macrophages
(Mo-Macs), suppress macrophage activation by TLR2, TLR4,
TLR5, and TLR8 ligands, and inhibit inflammatory cytokine pro-
duction in septic shock (Ramos-Benı´tez et al., 2017). They bind
to the TLR4 cofactor CD14 and reduce its expression, mediating
suppression of TLR4 responses. The Fh12 and Fh15 proteins
also suppress responses of CD14-deficient cells, suggesting806 Immunity 49, November 20, 2018further inhibitory functions (Martin et al.,
2015). Furthermore, cysteine proteases
from the flukes F. hepatica (FhCL1) and
S. mansoni (SmCB1) both directly sup-
press myeloid cell TLR signaling by inter-
fering with TLR-driven inflammation
in vivo, resulting in the intracellular degra-
dation of TLR3 and TLR4 (Donnelly
et al., 2010).
Conversely, some helminth molecu-
les stimulate, rather than inhibit, TLRs.
The phospholipid lysophosphatidylserine(lyso-PS) is enriched in the tegument of S. mansoni adult worms
(Retra et al., 2015). LysoPS is a TLR2 ligand that increases the
capacity of human DCs to drive IL-10-producing T cells, sup-
pressing T cell proliferation (van der Kleij et al., 2002). In contrast,
the 66-amino acid mucin-like polypeptide from F. hepatica
(Fhmuc), while not itself a TLR4 ligand, promotes LPS-induced
TLR4 activation of DCs, enhancing T helper 1 (Th1) cell re-
sponses, both in vitro and in vivo (Noya et al., 2017).
CLR signaling is important in responses to helminths, and
parasite-specific glycans are a rich source of ligands (Hokke
and van Diepen, 2017). The schistosome-specific GalNAc-di-
GalNAc (LDN) motif is bound by soluble galectin-3 (van den
Berg et al., 2004), while fucosylated (LDN-F) derivatives and
fucose-containing Lewis X (LeX) structures are bound by den-
dritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN).
Mannose-containing structures are recognized by mannose re-
ceptor (MR) and macrophage galactose-type lectin (MGL) (van
Die et al., 2003). Similar glycan ligands for these receptors are
also present in many other parasites including F. hepatica. Dur-
ing F. hepatica infection, glycan-CLR signaling induces a mixed
type 2 and regulatory phenotype with IL-10 and transforming
growth factor-b (TGFb) production (Rodrı´guez et al., 2017).
Schistosome glycans are strongly immunomodulatory (Mee-
vissen et al., 2012) with a predominant role in Th2 cell polariza-
tion through DCs: S. mansoni soluble egg antigen (SEA) induces
Th2 cell responses in vivo in a glycan-dependent manner (Okano
et al., 1999). The LNFPIII (lactose-N-fucopentose III) motif, pre-
sent in both on S. mansoni and in human milk, has similar DC-
modulating effects as total SEA (Thomas et al., 2005) and can
act as an adjuvant for a type 2 immune response (Okano et al.,
2001). LNFPIII also stimulates murine B cells to produce the
immunoregulatory cytokine IL-10 (Velupillai and Harn, 1994).
SEA and human milk also contain LNnT (lacto-N-neotetraose),
while intraperitoneally injected milk-derived LNnT induces the
influx of a macrophage population that produces IL-10 and
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barrier 
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GMCSF
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Figure 2. Helminth Modulators that Act on
the Early Innate Response to Damage and
Danger
Helminths and allergens can damage the epithelial
layer, resulting in the release of damage associ-
ated molecular patterns (DAMPs) and allowing
microbial ingress. DAMPs and pathogen associ-
ated molecular patterns (PAMPs) can be detected
by pattern recognition receptors on dendritic cells
and macrophages, resulting in their activation and
leading to antigen presentation. Alarmin cytokines
such as IL-25, IL-33, and TSLP are also released
by epithelial cells and can activate type 2 innate
lymphoid cells (ILC2s), which in turn can activate
(and be activated by) neurons. ILC2-derived type 2
cytokines aid in the initiation and amplification of
the type 2 immune response. Helminth immuno-
modulators are shown in blue.
Immunity
ReviewTGF-b and suppresses T cell proliferation (Terrazas et al., 2001).
Furthermore, schistosome glycans bind to the C-type lectin re-
ceptors Dectin-1 and Dectin-2 (Ritter et al., 2010) and prime
DCs for enhanced Th2 cell development via autocrine prosta-
glandin-E2 (PGE2) and OX40L (Kaisar et al., 2018), similar to
core a(1-3)-fucose- and b(1-2)-xylose-linked glycans (Faveeuw
et al., 2003). Other prominent helminth glycans include chitin, a
long-chain polysaccharide that is a potent type 2 response
inducer (Van Dyken et al., 2014).
If and when host myeloid cells are triggered through one or
more innate receptors, they initiate the proteolytic processing
of exogenous antigens and expression of a suite of key stimula-
tory markers and mediators. Helminths counter with a palette of
protein modulators, from protease inhibitors to receptor ligands,
that target these pathways. Among the inhibitors, cystatins inter-
ferewith cysteine proteases involved in antigen processing, such
as lysosomal cathepsins and asparaginyl endopeptidase (AEP).
The filarial cystatins, including CPI-2 from B. malayi, also specif-
ically inhibit AEP, allowing it toblock antigenprocessing in human
cells (Manoury et al., 2001), while LsCystatin (from Litomosoides
sigmodontis) reduces nitric oxide- and antigen-specific prolifera-
tive responses (Pfaff et al., 2002). In vitro, Onchocystatin (from
Onchocerca volvulus) induces IL-10 from human monocytes,
together with reduced MHC-II and CD86 expression (Scho¨ne-
meyer et al., 2001). In mouse models, AvCystatin (from
A. viteae) similarly drives macrophage IL-10 expression, damp-
ening both airway allergy and colitis (Dani1owicz-Luebert et al.,
2013). Furthermore, AvCystatin induces a regulatory PD-L1+
andPD-L2+macrophagepopulations,whichonadoptive transferprotect against both airway allergy and in-
testinal inflammation (Ziegler et al., 2015)
and reduce pollen-specific responses in
PBMCs from allergic patients (Dani1o-
wicz-Luebert et al., 2013).
Other helminth cystatins with broad
immunomodulatory properties including
those from S. japonicum (Wang et al.,
2016), Ascaris lumbricoides, and the liver
fluke Clonorchis sinensis all ameliorate
colitis in vivo (Coronado et al., 2017;
Jang et al., 2011), while Nippocystatin
from N. brasiliensis blocks responses toovalbumin (Dainichi et al., 2001). The physiological target of
these cystatins in vivo has yet to be identified. One possible
target might be protease-dependent inflammasome activation,
as their effects appear more generalized than interference with
the antigen processing machinery alone would predict.
In addition to interfering in myeloid PRR responses, helminths
also modulate myeloid cells through mimics of the host’s innate
immune messengers. Macrophage migration inhibitory factor
(MIF) proteins are evolutionarily ancient, but in mammals they
activate myeloid cells. MIF homologs are also found in nema-
todes (Vermeire et al., 2008): those from Brugia malayi (Zang
et al., 2002) and Trichinella spiralis (Tan et al., 2001) mirror the ac-
tivity of the host protein, inducing IL-8 release from monocytes,
while B. malayi MIF also potentiates alternative activation of
macrophages, in synergy with IL-4 (Prieto-Lafuente et al.,
2009). MIF from Anisakis simplex is directly anti-inflammatory,
ameliorating both allergy (Park et al., 2009) and colitis (Cho
et al., 2015) in mice. Therefore, homology to the host cytokine
does not always predict biological activity.
Further macrophage modulation is mediated by a F. hepatica-
secretedprotein termedhelminthdefensemolecule, orFhHDM-1.
FhHDM-1 is a homolog of the mammalian cathelicidin-like host
defense peptide (HDP) designated CAP18/LL-37. HDPs are anti-
microbial peptides that candisruptbacterialmembranesandsup-
press pro-inflammatory macrophage responses (Tecle et al.,
2010). FhHDM-1 binds LPS, preventing LPS ligation and activa-
tion of macrophages (Robinson et al., 2011). Furthermore,
FhHDM-1 is internalized bymacrophages andprocessedby lyso-
somal cathepsin L, releasing a short C-terminal peptide which inImmunity 49, November 20, 2018 807
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Reviewturn prevents the acidification of the endolysosomal compart-
ment, impairing antigen processing (Robinson et al., 2012) and
preventing NLRP3 inflammasome activation and IL-1b secretion
(Alvarado et al., 2017). In addition to its immune-modulatory ef-
fects, FhHDM-1 may have parasite-intrinsic functions, as it also
binds and detoxifies heme (Martı´nez-Serna´ndez et al., 2017).
More broadly, and beyond signaling pathways and antigen
processing, myeloid cell protein expression can be profoundly
affected by helminth molecules. For example, u-1 (Omega-1),
a glycoprotein released by S. mansoni eggs, is a T2 ribonuclease
(RNase). It is taken up by DCs through recognition of its glycan
moiety, Lewis-X, by the mannose receptor, and extinguishes
protein synthesis through the degradation of ribosomal RNA
and mRNA within the cell. Omega-1 does not degrade specific
transcripts, but rather targets the global pool of RNA. In
this way omega-1, and its close homolog from Schistosoma
japonicum, CP1412, suppress DC activation and maturation,
preventing upregulation of CD86 and MHCII and synthesis of
IL-12 in response to CD40 ligation, favoring both Th2 cell
(Everts et al., 2012; Everts et al., 2009; Steinfelder et al., 2009;
Wilbers et al., 2017) and regulatory T (Treg) cell (Ke et al.,
2017; Zaccone et al., 2011) induction. T cell priming in the
absence of IL-12 and with diminished co-stimulation may favor
Th2 cell polarization.
The Th2 cell-mediated priming capacity of omega-1 has also
been confirmed in vivo using lentivirus-based transduction to
silence gene expression in schistosome eggs, as intravenous in-
jections of those eggs shows reduced lung granuloma formation
compared to sham-transduced eggs (Hagen et al., 2014). Lastly,
omega-1 induces inflammasome-dependent IL-1b in TLR2-
stimulated peritoneal macrophages, which is abrogated when
blocking Dectin-1, suggesting that omega-1 can modulate mul-
tiple PRR pathways (Ferguson et al., 2015).
The modulatory effects of omega-1 were recently extended to
changes in host metabolism. A series of recent studies have
demonstrated the beneficial effects of helminth infection on
host metabolism (Crowe et al., 2017; Wiria et al., 2014), which
can be replicated by helminth products such as SEA (Hussaarts
et al., 2015; Wolfs et al., 2014) or recombinant omega-1 (Hams
et al., 2016). Injection of omega-1 into obese mice improves in-
sulin sensitivity via IL-33 release from white adipose tissue,
which in turn induces ILC2 activation and alternatively activated
M2 macrophage differentiation. Mechanistically, the release of
IL-33 is mediated by the RNase activity of omega-1, while the
improved insulin sensitivity was dependent on the ligation of
the mannose receptor (Hams et al., 2016).
Another example showing myeloid cell signaling manipulation
is from B. malayi abundant larval transcript (ALT). The mosquito-
borne B. malayi larvae stockpile quantities of ALT proteins prior
to entry into the mammalian host. Investigation of gene function
by a transfection approach within macrophages identified ALT-
induced upregulation of SOCS1, the inhibitor of IFN-g signaling
in inflammation (Gomez-Escobar et al., 2005).
Finally, some helminth proteins contain a nuclear localization
signal (NLS) for rapid translocation to the nucleus, including
the S. japonicum-derived molecule Sj16, which induces IL-10
and inhibits DC maturation following nuclear translocation (Sun
et al., 2016). IL-4-inducing principle from schistosome eggs
(IPSE) is also rapidly translocated to the nucleus of DCs upon808 Immunity 49, November 20, 2018uptake (Kaur et al., 2011), while the IPSE homolog from
S. haematobium (H-IPSE) translocates to the nucleus of bladder
epithelial cells (Pennington et al., 2017). Here, H-IPSE reduces
bladder hemorrhage and accelerates urothelial repair in a
chemotherapy-induced hemorrhagic cystitis (CHC) model (Mba-
nefo et al., 2018). The therapeutic effects are IL-4 dependent and
may relate to its IL-4-inducing capacity described in basophils
(detailed below). The effects of H-IPSE are, however, superior
to IL-4 alone, implying that additional nuclear functions are
involved (Mbanefo et al., 2018).
The end result of parasite modulation of dendritic cell and
macrophage modulation is often aberrant, skewed, or tolerized
T cell responses. In the next section we will deal with helminth
products that act directly on adaptive immune responses.
Adaptive Response Modulation Is Targeted at Multiple
Levels
On activation by APCs, naive T cells can differentiate into Th1,
Th2, Th17, or Treg cell subsets. Modulation of adaptive immune
responses has the potential for lasting effects in the host: if the
parasite can appear as harmless or commensal, a memory
response can be raised that treats the parasite as ‘‘self.’’ Para-
sitic helminths have developed multiple suppressive and modu-
latory pathways that suppress effector and/or induce regulatory
T helper and B cell responses (Figure 3).
An example of both homologous and de novo-generated im-
munomodulators from helminth parasites can be found in para-
site agonists of the TGF-b receptor. The effects of host immune
TGF-b signaling are diverse, but are largely immunosuppressive,
with generation of induced regulatory T cells, suppression of
dendritic cell, macrophage, and T cell activation, and skewing
of antibody isotypes to IgA (Chen and Ten Dijke, 2016). Thus,
stimulation of the TGF-b pathway would be advantageous to
an immunity-shy parasite.
The ancestral function of the TGF-b pathway, across the ani-
mal kingdom, is in development: the immunomodulatory role of
TGF-b is a more recent adaptive branch within vertebrates
(David and Massague, 2018). Notably, ligands and receptors
show a high degree of conservation allowing, for example,
S. mansoni and Echinococcus multilocularis TGF-b receptors
to ligate human TGF-b family ligands (Beall and Pearce, 2001;
Zavala-Go´ngora et al., 2006). The question is whether TGF-b
family members from helminths activate immunosuppressive
mechanisms in mammalian cells; indeed, B. malayi TGH-2 can
signal through the TGF-bR (Gomez-Escobar et al., 2000) while
extracts from L. sigmodontis also ligate the TGF-bR in a manner
that cannot be inhibited with antibodies to TGF-b itself (Hart-
mann et al., 2015). Finally, a TGF-b homolog from F. hepatica,
FhTLM, binds host receptors, but with lower affinity and this
was inhibited by polyclonal anti-TGF-b antibodies. Immunologi-
cally, FhTLM induces IL-10 production in macrophages, indica-
tive of a pro-regulatory outcome (Sulaiman et al., 2016).
In contrast to these instances of evolutionarily conserved
members of the TGF-b family activating host receptors, a strik-
ing example of convergent evolution has been found in
H. polygyrus. Secreted products from this intestinal nematode
have been shown to activate the TGF-b signaling pathway to
induce regulatory T cells in vitro, even in the presence of pro-in-
flammatory cytokines and to a similar degree as TGF-b itself
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Figure 3. Helminth Modulators that Act on
the Adaptive and Effector Immune
Responses
Immune responses are controlled by helper T cell
responses (Th1, Th2, or Th17) and B cell antibody
responses. These responses can counter-regu-
late each other and are suppressed by regulatory
T cell or regulatory B cell responses. Effector
responses are mediated by T cell-derived cyto-
kines which act on innate effector cells such as
macrophages, eosinophils, basophils, and neu-
trophils. Helminth immunodulators are shown
in blue.
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tionation, the factor responsible has been identified as an unre-
lated structure named TGM (TGF-b Mimic), a 5-domain protein
around three times larger than TGF-b and able to bind with high
affinity to both TGF-bRI and II, in distinction to mammalian TGF-
b which ligates only to RII (Johnston et al., 2017). TGM is also
active in vivo, for example in prolonging survival of fully alloge-
neic skin grafts (Johnston et al., 2017). Similarly to HpARI,
HpTGM is also effective in cultures of human T cells, despite
H. polygyrus lacking infectivity in humans.
While the TGF-b pathway directly induces regulatory T cells,
other helminth mediators exploit indirect pathways to modulate
host T cells. Hookworm-derived homologs of the tissue inhibitor
of metalloproteases (TIMPs) modulate DC function, resulting in
tolerogenic T cell responses (Cue´llar et al., 2009) and more
recently these proteins (now called AIP-1 and AIP-2, for anti-
inflammatory proteins) have been demonstrated to be effective
quenchers of pathology in mouse models of airway allergy (Nav-
arro et al., 2016) and TNBS-induced colitis (Ferreira et al., 2017).
Protection is associated with increased Treg cell and IL-10 re-
sponses, alongside abated inflammatory cytokines andmodified
DC function. Effects are also seen in cultured human DCs and
T cells, indicating potential as therapeutics for immune disorders
(Navarro et al., 2016).
Treg cell induction in vivo is also seen with PAS-1, a 200-kDa
native protein purified from Ascaris suum, which is reported to
inhibit airway allergy in ovalbumin-alum primed mice (Arau´jo
et al., 2008). PAS-1 induces an expands CD25+ Treg cell pop-
ulations, which can suppress allergic responses on adoptive
transfer (de Arau´jo et al., 2010). PAS-1 is similar to ABA-1, a
previously described nematode tandemly repeated polyprotein
with lipid-binding properties (Antunes et al., 2015; Meenan
et al., 2011).
Host galectins promote Treg cell functionality and stability,
and a homolog of human galectin-9 from Toxascaris leonina
reduces DSS-induced colonic pathology in mice with increasedproduction of IL-10 and TGF-b (Kim et al.,
2010). While the mechanism is assumed
to parallel that of human galectin-9, this
has not been verified for the helminth
homolog.
Effector T cells are also targeted by
certain products. The schistosome gluta-
thione-S-transferase protein (P28GST)
appears to promote a sufficiently strong
eosinophil-rich Th2 cell response to pre-vent Th1 and Th17 cell-mediated inflammation in murine co-
litis in an eosinophil-dependent manner (Driss et al., 2016).
In contrast, the Echinococcus multilocularis homolog of TIP
(EmTIP) induces IFN-g release from CD4+ T cells in vitro, which
may explain how this parasite, unlike most other helminths, in-
duces an initial Th1 cell response in vivo (Nono et al., 2014).
Potassium channels in lymphocytes, such as voltage-gated
channel Kv1.3, are crucial for the activation and proliferation of
T cells. Kv1.3 is considered an interesting therapeutic target in
autoimmune conditions and inhibitors include ShK, a polypep-
tide toxin expressed in the sea anemone Stichodactyla helian-
thus (Norton et al., 2004). ShK homologs have been conserved
and adapted in helminth T cell inhibitors, e.g., AcK1, found in
the hookwormsAncylostoma caninum andAncylostoma ceylani-
cum, and BmK1, identified in the filarial worm B. malayi. These
peptides suppress a delayed-type hypersensitivity (DTH) reac-
tion in rats and inhibit primarily the proliferation of memory
T cells without affecting naive or central memory subsets (Chha-
bra et al., 2014).
An equally important target for helminth parasites is the host
B cell response, which is known to be crucial for parasite ejec-
tion (Harris and Gause, 2011). Na-ASP-2 (Ancylostoma secreted
protein 2 expressed by N. americanus) binds to CD79A, a
component of the B cell receptor (BCR) complex, downregulat-
ing mRNA expression of targets involved in signaling and trans-
endothelial migration (Tribolet et al., 2015) while ES-62 from
A. viteae uncouples the BCR signaling machinery, rendering
host cells unresponsive (Deehan et al., 2001). Other types
of regulation of B cell responses in helminth infection are
associated with a switch from the IgE to the IgG4 isotype, and
a regulatory B cell (Breg) phenotype characterized by produc-
tion of IL-10 (Hussaarts et al., 2011), similar to changes in
B cell phenotypes found in allergen tolerance (Akdis and Akdis,
2014).
The secreted products of S. mansoni eggs can induce a regu-
latory B (Breg) cell phenotype inmurine and human cells, throughImmunity 49, November 20, 2018 809
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Uptake of IPSE is necessary to induce B cell IL-10 and Treg
cell development in vitro (Haeberlein et al., 2017). IPSE also sup-
ports type 2 cell responses, through induction of IL-4 release
from basophils that is IgE dependent but antigen independent
and does not require uptake of IPSE by basophils, so this single
protein has multiple functions and activation routes (Schramm
et al., 2007).
By modulating CD4+ T cell differentiation, Treg cell induction,
B cell isotype switching, and Breg cell induction, parasites can
produce an environment most suited to them. These adaptive
responses then determine effector cell responses and whether
the outcome of infection is inflammation, resolution, parasite
ejection, or tolerance.
Helminth Molecules Defeat Effector Cell Responses
The full spectrum of cell populations are involved in defense
against helminths, from ‘‘professional’’ immune leukocytes to
stromal and epithelial cells. In particular, granulocytes (eosino-
phils and neutrophils) are often the final effector cells in allergic
and inflammatory responses, able to target the site of infection
and kill pathogens by a variety of means including delivery of
toxic compounds, sequestering vital nutrients, and destabilizing
the parasite environment. Therefore, parasite survival can be
maintained through secretions that block effector cell recruit-
ment and function.
Chemokines are crucial in organizing the immune response
through migration of immune cells to sites of inflammation.
A key chemokine required for immune cell recruitment and acti-
vation in humans is IL-8. B. malayi produces asparaginyl-tRNA
synthetase (AsnRS) which shows structural (but not sequence)
homology to IL-8 and binds the IL-8 receptors CXCR1 and
CXCR2, recruiting eosinophils and neutrophils (Kron et al.,
2013). However, despite this apparently pro-inflammatory
mechanism of action, administration of AsnRS in the mouse
T cell transfer model of colitis induces regulatory responses
and induction of IL-10 (Kron et al., 2013).
Conversely, human hookworms suppress chemokine re-
sponses through production of metalloproteinases which cleave
eotaxin-1 (CCL11), but not IL-8 or eotaxin-2 (CCL24), specifically
inhibiting the eotaxin-mediated recruitment of eosinophils
(Culley et al., 2000). S. mansoni secretes a chemokine binding
protein (SmCKBP) which binds and blocks IL-8, CCL2, CCL3,
CCL5, and CX3CL1—this action inhibits neutrophil (but not
eosinophil) migration and has suppressive activity in the DNFB
contact hypersensitivity model, while blocking SmCKBP in vivo
resulting in increased neutrophilia in S. mansoni egg-induced
granulomas (Smith et al., 2005).
In concert with chemokines, cell migration also requires inter-
action with integrins such as CD11b/CD18 to facilitate extrava-
sation. One hookworm protein, NIF from Ancylostoma caninum,
binds this integrin together with fibrinogen and prevents binding
of human neutrophils to vascular endothelium (Moyle et al.,
1994). NIF is also effective in in vitro models of LPS-driven pul-
monary inflammation (Zhou et al., 1998), and a NIF-IgE Fc fusion
protein (NIF-IGHE-CH4) suppresses human neutrophil migration
and blister formation in an ex vivo humanmodel of subepidermal
autoimmune blistering disease (Kemmer et al., 2015). Remark-
ably, NIF is a member of a multi-gene family (Pfam00188, vari-810 Immunity 49, November 20, 2018ously named CAP, SCP, TAPS, or VAL) that is prominent across
a wide range of helminths, and which includes a wide variety of
immune response modulators in both animals and plants (Wilb-
ers et al., 2018).
After responding to an infection, the host must heal after
epithelial damage and inflammation. This can be mediated
by immune pathways and helped (or hindered) by parasite
products.
Helminths Can Promote Healing and Remodeling
As parasites enter the host, theymust digest connective tissue to
allow their migration, followed by rapid healing tomaintain health
of their host. They achieve this through secretion of proteases
and other ‘‘chemical scissors’’ essential for the invasive process
(Ranasinghe and McManus, 2017). Their entry is also facilitated
by inhibiting coagulation, particularly prominent in blood-dwell-
ing helminths like schistosomes with multiple strategies to
manipulate host vasodilation, fibrinolysis, and coagulation (Me-
bius et al., 2013). Calpain family proteases SmCalp-1 and
SmCalp-2 are expressed in the tegument of S. mansoni adult
worms, where they appear to cleave and inactivate key coagula-
tion proteins fibronectin and high-molecular-weight kininogen
(HK) (Wang et al., 2018).
As discussed above, ATP-degrading enzymes (apyrases) are
commonly secreted by helminths, suppressing DAMP-induced
inflammatory responses. However, these enzymes have further
roles in the control of thrombosis, as extracellular ATP and
ADP are potent activators of platelets. Schistosome teguments
contain ATP diphosphohydrolase (SmATPDase1) (Da’dara
et al., 2014) and the ectonucleotide pyrophosphatase/phospho-
diesterase homolog SmNPP5 (Elzoheiry et al., 2018), both of
which degrade ATP and ADP to non-thrombotic AMP.
Conversely, a serine protease-2 (SmSP-2) has been found to
activate tissue plasminogen activator and plasminogen, both
key components of the fibrinolytic system (Leontovyc et al.,
2018). Similar activities have been described for other parasite
secretions, such as the cathepsin L peptidases FhCL-1, -2,
and -3 from F. hepatica, which degrade fibrinogen and fibrin
(Mebius et al., 2018), and a plasminogen-binding alpha-enolase
from O. volvulus (OvENO), which may promote proteolysis and
degradation of the host extracellular matrix for migration of
larvae through host tissues (Jolodar et al., 2003).
Parasite secretions can also encourage the healing of the
epithelium. An extreme example of this is the bile duct-dwelling
trematode Opisthorcis viverrini. This trematode feeds on bile
duct epithelial cells and causes extensive inflammation in situ.
It secretes a granulin homolog (Ov-GRN-1) which causes epithe-
lial cell proliferation: this has potential as a therapeutic agent for
non-healing wounds (Smout et al., 2015), but during infection
can also result in epithelial transformation and contributes to
mortality in O. viverrini infection due to cholangiocarcinoma
(Smout et al., 2009).
Thus, the secretions of parasitic helminths canmodulate every
phase of immunity, from the most proximal events in immune
initiation to terminal effector responses. In the next section we
will discuss how these recent research findings could lead to
the discovery of further parasite immunomodulators and how
these could be developed for use in human immune-mediated
diseases.
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Figure 4. The Evolution and Diversity of Helminth Immunomodulation
(A) The TGF-b family is evolutionarily ancient, and nearly all helminth genomes (including free-living helminths) encode TGF-b family members. TGF-b homologs
from Brugia malayi (Bm-TGH-2) and Fasciola hepatica (FhTLM) have co-evolved with their host to bind to the mammalian TGF-b receptor.
(B) In Heligmosomoides polygyrus, the CCP domain-containing family is over-represented in the genome, and HpTGM (a 5 CCP domain protein) has undergone
convergent evolution to bind the TGF-b receptor, despite bearing no homology to the host cytokine. The CCP domain family in H. polygyrus appears highly
adaptable, and the IL-33-blocking protein HpARI also consists of 3 CCP domains.
(C) T2 ribonucleases are involved in a number of homeostatic processes including RNA recycling, and most helminth genomes contain a member of this family.
In the schistosomes, however, the T2 ribonuclease family has undergone expansion, and the T2 ribonucelase omega-1 (u-1) is secreted into the host, where it
gains entry to dendritic cells (DCs) through its Lewis X motifs which are bound by glycan receptors. Once inside the DC, omega-1 degrades host messenger
and ribosomal RNA, suppressing DC activation and downstream T cell responses.
Blue arrows indicate evolutionary processes, black arrows indicate binding. Graphs show number of members of families in each group of genomes (WormBase
ParaSite), represented as box and whiskers representing minimum to maximum values.
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The field of helminth immunomodulators has, until now, been
dominated by protein actors, a tendency likely to continue with
the torrent of sequence information extending to more than
100 helminth genomes, each with >10,000 protein-coding genes
(International Helminth Genomes Consortium, 2018). Protein
sequence analyses also provide insights into the molecular evo-
lution of the different families of helminth immunomodulators
(Figure 4). However, this should not overshadow the critical
role of non-protein components (alone or in concert with protein
moieties), which playmany critical roles in helminth immunology.
A relatively neglected aspect of helminth biology has been
their production of small molecules with potential for immune
modulation, such as prostaglandins and short-chain fatty acids
(SCFAs). Some helminths, for example Ascaris, release acetate
and other metabolites likely to impact responses of the epithe-lium (Tielens et al., 2010). In addition, helminths can modify the
commensal microbiota in a fashion that raises SCFA concentra-
tions, indirectly promoting regulatory mechanisms in the host
(Zaiss et al., 2015). With metabolomics now being applied to
helminths and genomics piecing together parasite biosyn-
thetic pathways, the suite of such small molecules is likely to
now expand rapidly and uncover many more critical interactions
in host recognition and immune control. In a recent demonstra-
tion of this, small molecules fromA. caninum suppressed pathol-
ogy in a mouse model of TNBS-induced colitis (Wangchuk
et al., 2018).
Lipid mediators are among the most potent small molecules in
the host immune system, both activating and suppressing the
immune response. They are <1 kDa, intensely active within their
milieu, and have conserved chemical structures across multiple
hosts. They represent a target for parasite neutralization orImmunity 49, November 20, 2018 811
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fects. PGE2 is an arachadonic acid metabolite, with roles in
ILC2, T helper cell, macrophage, dendritic cell, and neutrophil re-
sponses (Martı´nez-Colo´n and Moore, 2018). PGE2 is strongly
linked to Th2 cell and ILC2 responses, for example inducing
IL-22-mediated atopic dermatitis (Robb et al., 2018), although
it can also directly inhibit ILC2s (Maric et al., 2018). T. suis,
S. mansoni, and filarial nematode secretions contain PGE2
(Laan et al., 2017; Liu et al., 1992), and S. mansoni SEA has
the ability to induce further PGE2 from host cells (Kaisar et al.,
2018), in this case mediating Th2 cell induction.
In the context of the pivotal role of lipid mediators, more atten-
tion is likely to be focused on lipid-binding proteins that are
numerous among helminth products (Franchini et al., 2015).
For example, F. hepatica Fh12 (also known as fatty acid binding
protein) mentioned above induces alternative activation in
human Mo-Macs and suppresses LPS-induced activation via
binding and blocking of CD14.
A paradigm-shifting discovery has been that helminths release
extracellular vesicles (EVs), often termed exosomes, which are
able to fuse and enter host cells, carrying with them a cargo
of miRNAs (Buck et al., 2014; Coakley et al., 2017). In
H. polygyrus infections, these EVs target epithelial cells and
macrophages, resulting in their loss of expression of the IL-33
receptor (IL-33R, also termed ST2) and downregulation of other
immune genes. These effects result in suppression of both alter-
native and inflammatory macrophage activation (Coakley et al.,
2017). These in vitro findings have been corroborated in vivo,
as N. brasiliensis EVs protect against TNBS-induced colitis
(Eichenberger et al., 2018), andH. polygyrus EVs suppress Alter-
naria allergen-induced allergic airway responses (Buck et al.,
2014). In contrast, EVs from S. japonicum actively drive M1
macrophage differentiation in vitro (Wang et al., 2015), joining a
range of helminth-secreted proteins that counter-intuitively
induce inflammatory responses (Kron et al., 2013; Noya et al.,
2017). Hence EVs are an adaptable part of the armory of helminth
immunomodulators, allowing extracellular pathogens to manip-
ulate events within host cells in a receptor-independent manner
(Coakley et al., 2017). Further research is required in this area, to
investigate the level of specificity of particular EV populations for
specific host cells, to determine the relative importance of EV
protein and nucleic acid cargoes, and to develop these findings
toward potential therapeutic agents for human disease.
Identification, Characterization, and Clinical
Development of the Next Generation of Parasite
Immunomodulators
As the identification of defined immunomodulators accelerates,
the scale of what the future may hold is also becoming apparent.
Each large and complex helminth genome can encode 10,000–
50,000 genes (Zarowiecki and Berriman, 2015) (compared to
20,000 in the human genome), and as a result many million pre-
viously unannotated genes are now being cataloged. Moreover,
parasite secretions are extremely complex, containing hundreds
to thousands of protein, carbohydrate, lipid, nucleotide, and
vesicular moieties, each of which may be finely tuned to a partic-
ular host range.
Parasitism has arisen on multiple occasions within the hel-
minth phyla, and each lineage has evolved specific molecular812 Immunity 49, November 20, 2018strategies to defeat the host immune system. As helminths are
metazoan members of the animal kingdom, they share many
gene families with vertebrates that might provide a template
for the molecular evolution of modulators interactive with coun-
terparts in the host. Thus, as the host-adapted genes in the evo-
lution of the immune system, parasites may have followed suit in
parallel. Some cases, described below, appear to fulfil this pre-
diction. In contrast, however, some of the most striking parasite
immunomodulators such as HpARI, HpTGM, omega-1, and
IPSE show no appreciable homology to host immune genes or
previously known parasite immunomodulatory factors.
Immunomodulators derived from an ancient shared ancestor
of both parasites and their hosts include the TGF-b and MIF
families. In the case of TGF-b, a gene family originally required
for developmental processes expanded to encompass mem-
bers with cytokine functions. Thus, as the host developed
an immunological role for TGF-b, some parasites have been
able to adapt pre-existing developmental homologs toward an
immune-modulatory role. Therefore, the TGF-b homologs en-
coded in parasite genomes do not necessarily indicate immune
modulatory functions, while conversely a single TGF-b homolog
may fulfil both developmental and immunomodulatory roles
(Figure 4A).
It was recently discovered that, rather than adapt a pre-exist-
ing TGF-b homolog to interact with host receptors, H. polygyrus
has convergently evolved an unrelated structure in the form of
Hp-TGM, a protein consisting of five atypical complement con-
trol protein (CCP) domains with no homology to TGF-b, which
ligates host TGF-b receptor (Johnston et al., 2017; Smyth
et al., 2018). Furthermore, the same parasite blocks IL-33
through HpARI, another CCP domain protein (Osbourn et al.,
2017). Although CCP domains are present in all helminths stud-
ied, there has been a preferential expansion of these genes in
H. polygyrus (Figure 4B). CCP domains occur in a wide range
of organisms and serve diverse functions in neuronal signaling,
cytokine receptors, hemoglobin binding, and of course, com-
plement control. CCP domain proteins are highly stable and sol-
uble (each tight, globular CCP domain contains two disulfide
bonds and conserved glycosylation), structurally simple but
functionally sophisticated (Makou et al., 2015) with independent
activities of multiple domains within a single protein. This adapt-
able scaffold appears to have been exploited by H. polygyrus in
particular.
Gene family expansion in helminths hints at functional adap-
tation to the parasitic life style. Among the most notable is
Pfam00188, which in helminths include venom allergen-like
(VAL) and Ancylostoma secreted (ASP) proteins. This gene fam-
ily is dramatically expanded in many parasitic nematodes
(especially the hookworms and strongylides) and have been
implicated in lipid binding, immune modulation, and pathogen
resistance, so they may, like the CCP domain family, represent
an adaptable scaffold upon which a range of functions can be
developed (Wilbers et al., 2018).
Conversely, expansion of the T2 ribonuclease family (contain-
ing omega-1) (Everts et al., 2012) appears specific to schisto-
somes (Figure 4C), implying that this functionality may have
evolved within the trematode family relatively recently. T2 ribo-
nucleases are broadly expressed across many parasites, plants,
and animals and are implicated in recycling of RNA and in RNA
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Reviewdegradation during the stress response. T2 ribonucleases typi-
cally enter the secretory pathway and are often found in vacuoles
and autophagosomes within cells. However, some T2 ribonucle-
ases (for instance Erns from pestiviruses) can also be secreted
(Luhtala and Parker, 2010), for degradation of RNA in extracel-
lular spaces or in target cells, and it is this latter function which
appears to have been utilized in the schistosomes, degrading
RNA in host DCs and suppressing their maturation (Everts
et al., 2012). Thus, schistosomes have ‘‘weaponized’’ a normal
metabolic pathway to suppress DC maturation.
Similarly the apyrase family, which is expanded in many para-
sitic nematodes (International Helminth Genomes Consortium,
2018), may have originally been a metabolic enzyme but have
subsequently used to suppress of host damage detection
and inhibit blood coagulation (Da’dara et al., 2014; Gounaris
et al., 2004).
These examples of helminth modulation exemplify the tech-
niques used by helminths to develop immunomodulatory prod-
ucts: convergent evolution of shared protein families, de novo
production of cytokine mimics or antagonists from adaptable
modular domains, and hi-jacking of pre-existing protein func-
tions. The agenda for the future is to test whether administration
of defined helminth-derived molecular entities (with known func-
tions and in a specific context) can lead us to clinically effective
therapeutic molecules.
Molecular Therapies from Helminths—Where Are We?
In 2005, the first helminth therapy trials (using liveT. suis infection)
showed impressive effects in IBD (Weinstock and Elliott, 2013)
and generated a great deal of interest in the use of live
helminths as therapeutic modalities. However, subsequent
trials have shown smaller or absent effect sizes (Feary et al.,
2010; Fleming et al., 2017; Scho¨lmerich et al., 2017), and a lack
of understanding of the mechanistic underpinning of helminth
immunomodulation has hampered progression. With the recent
advances in understanding of helminth immunomodulation at
the molecular level, enormous potential exists for helminth-
derived products for clinical use.
ES-62 was one of the original immunomodulatory molecules
identified from parasites and with its activity through the small
molecule phosphorylcholine (PC) moiety, it has great potential
for therapeutic drug-like molecules. Two small molecule analogs
(SMAs) of PC, termed 11a and 12b, can replicate many of the
suppressive effects of ES-62, and due to their small size, stabil-
ity, and lack of immunogenicity and efficacy are now being
developed as therapeutic agents (Al-Riyami et al., 2013). Simi-
larly, many of the recently identified immunomodulatory proteins
are likely to be pursued as potential anti-inflammatory therapeu-
tics for clinical use. These proteins have evolved to function in
the mammalian milieu and represent natural biologicals that
may offer unique mechanisms of action not available with exist-
ing drugs; in this context, the coming years of translational
research promise to be very engaging.
We summarize here a remarkable panoply of helminth mole-
cules which, when tested in isolation in vitro or in vivo, target
distinct host populations and pathways. Little is yet known, how-
ever, of how products from parasites in specific niches (such as
the intestinal lumen) are able engage the broader host immune
system, whether they exploit uptake mechanisms for systemicdissemination or rely on localized effects in their preferred site.
Certainly, in species such as H. polygyrus, secretion products
differ markedly between immature tissue-dwelling larvae and
the intestinal lumen-dwelling adults (Hewitson et al., 2013),
arguing for developmental adaptability for interaction with the
immune system. In other cases, blood-dwelling parasites such
as schistosomes or lymphatic-dwelling filarial worms have
more direct access to immune cells and may more readily exert
a systemic effect.
Although parasite immunomodulators may act potently in lab-
oratory tests, one obstacle to clinical development has been
potential immunogenicity as foreign proteins in vivo. However,
immunogenicity of helminth immunomodulators would repre-
sent an adverse outcome for the parasite, and thus mechanisms
may be in place (including the innately immunosuppressive
nature of these molecules) for avoidance of this: the fully foreign
hookworm product AIP-2 is minimally immunogenic in vivo (Nav-
arro et al., 2016).
There are also good precedents for the development of path-
ogen-derived proteins that have been successfully developed
for human use, despite concerns of immunogenicity. Streptoki-
nase (a Streptococcus-derived thrombolytic) has been used for
decades in thrombotic disease such as myocardial infarction.
Although highly immunogenic, as long as the drug is not repeat-
edly administered, it is effective and its immunogenicity does
not present a barrier to use (Sikri and Bardia, 2007). Likewise,
the myxoma viral protein Serp1 is an anti-inflammatory inhibitor
of serine proteases; administration of Serp1 causes a non-
neutralizing antibody response and subsequently the functional
activity of the protein has been extended (and potential immu-
nogenicity decreased) through development of small peptide
mimetics that replicate the function of the full protein (Ambada-
padi et al., 2016). Therefore, formulations of helminth immuno-
modulators are being developed in which immunogenicity is not
present, or is not a barrier to use, for future therapeutic appli-
cations.
Conclusions
Helminth immunomodulation is coming of age. Through ad-
vances in -omics analysis of parasitic helminths, ever more
information about helminth products is becoming available.
However, only by careful analysis of defined recombinant prod-
ucts can the potential of helminth therapeutic agents be realized.
In recent years this has led to the characterization of a handful of
helminth immunomodulators that could be developed for use in
the clinic. Considering the size and complexity of helminth secre-
tions, the complex interaction with their host, and the intricacy of
the immune response directed against them, it appears almost
certain that we have only scratched the surface of the full gamut
of helminth immunomodulators, and thatmanymorewill be iden-
tified in the next decade.
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